| MEG3 |
Down |
Down-regulated MEG3 was significantly associated with TNM stage and LNM in BC patients. |
[20] |
| OR3A4 |
Up |
The expression level of OR3A4 was found to be associated with LNM, differentiation grade, HER-2/neu status, and TNM stage. |
[23] |
| H19 |
Up |
Plasma levels of lncRNA H19 were significantly correlated with LNM. |
[87] |
| TUG1 |
Down |
Low TUG1 expression was significantly correlated with LNM. |
[88] |
| FGF14-AS2 |
Down |
Down-regulation of lncRNA FGF14-AS2 was correlated with more lymph node metastasis. |
[89] |
| AC010729.1 |
– |
Increased expressions of AC010729.1 and RP11-482H16.1 had a shorter MFS compared with patients with low expressions of AC010729.1 and RP11-482H16.1. |
[90] |
| RP11-482H16.1 |
| AC010729.1 |
| RP11-482H16.1 |
| MALAT1 |
Up |
Up-regulated MALAT1 was related to LNM. |
[91] |
| HOTAIR |
Up |
HOTAIR increased in the metastatic carcinomas and its expression in BC was a predictor of poor survival. |
[92] |
| Z38 |
Up |
High level of Z38 was significantly related to advanced TNM stage and LNM. |
[93] |
| LINC01296 |
Up |
Increased LINC01296 was positive correlated with larger tumor size, positive LNM, and advanced TNM stage of patients with BC. |
[94] |
| p10247 |
Up |
The up-regulated expression of p10247 was significantly associated with progression of clinical stage and LNM. |
[95] |
